Medicare Enrolled
Dr. Stephen Gold, D.O.
Family Medicine · Lancaster, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gold from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gold?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gold
Dr. Stephen Gold is a family medicine specialist in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gold performed 1,279 Medicare services across 665 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gold received a total of $68,955 from 95 pharmaceutical and/or device companies across 2033 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gold is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in PA
$68,955 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,279
Medicare services
Top 18% in PA for family medicine
665
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
388 | $52 | $141 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
333 | $81 | $188 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
218 | $8 | $10 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
161 | $43 | $70 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
73 | $119 | $145 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $23 | $115 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
14 | $3 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $133 | $209 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
13 | $39 | $75 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
11 | $12 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $106 | $214 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
11 | $154 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$68,955
Total received (2018-2024)
Avg $9,851/year across 7 years
Top 1% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
95
Companies
2,033
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36,869 (53.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,822 (44.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,263 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,095
2023
$20,899
2022
$7,210
2021
$10,282
2020
$6,043
2019
$5,150
2018
$4,276
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$10,628
AstraZeneca Pharmaceuticals LP
$684
PFIZER INC.
$525
Novo Nordisk Inc
$506
Phathom Pharmaceuticals, Inc.
$382
Lilly USA, LLC
$340
Boehringer Ingelheim Pharmaceuticals, Inc.
$222
Teva Pharmaceuticals USA, Inc.
$196
IRONWOOD PHARMACEUTICALS, INC
$194
Bayer Healthcare Pharmaceuticals Inc.
$188
Merck Sharp & Dohme LLC
$136
Antares Pharma, Inc.
$134
Corcept Therapeutics
$124
Neurocrine Biosciences, Inc.
$119
Abbott Laboratories
$98
Exact Sciences Corporation
$88
Astellas Pharma US Inc
$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$75
GlaxoSmithKline, LLC.
$58
Janssen Pharmaceuticals, Inc
$56
Otsuka America Pharmaceutical, Inc.
$54
Axsome Therapeutics, Inc.
$48
Kowa Pharmaceuticals America, Inc.
$36
IDORSIA PHARMACEUTICALS US INC
$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$33
Inspire Medical Systems, Inc.
$23
Seqirus USA Inc
$15
Amgen Inc.
$14
Top 3 companies account for 78.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$29,021
AbbVie Inc.
$5,770
AstraZeneca Pharmaceuticals LP
$4,879
Novo Nordisk Inc
$4,139
PFIZER INC.
$2,408
Allergan, Inc.
$1,710
Lilly USA, LLC
$1,631
GlaxoSmithKline, LLC.
$1,433
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,172
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$889
Novartis Pharmaceuticals Corporation
$861
SANOFI-AVENTIS U.S. LLC
$840
Otsuka America Pharmaceutical, Inc.
$810
Merck Sharp & Dohme Corporation
$782
Teva Pharmaceuticals USA, Inc.
$648
Axsome Therapeutics, Inc.
$600
Amgen Inc.
$598
Allergan Inc.
$507
Amarin Pharma Inc.
$476
Astellas Pharma US Inc
$457
Phathom Pharmaceuticals, Inc.
$417
Biohaven Pharmaceutical Holding Company Ltd.
$386
Merck Sharp & Dohme LLC
$385
Bayer HealthCare Pharmaceuticals Inc.
$370
E.R. Squibb & Sons, L.L.C.
$365
Sunovion Pharmaceuticals Inc.
$350
Supernus Pharmaceuticals, Inc.
$348
Abbott Laboratories
$311
Biohaven Pharmaceuticals, Inc.
$292
ITI, Inc.
$292
Takeda Pharmaceuticals U.S.A., Inc.
$272
Bayer Healthcare Pharmaceuticals Inc.
$270
Janssen Pharmaceuticals, Inc
$262
Corcept Therapeutics
$259
Esperion Therapeutics, Inc.
$254
IRONWOOD PHARMACEUTICALS, INC
$220
Inari Medical, Inc.
$209
Ironwood Pharmaceuticals, Inc
$206
Lundbeck LLC
$183
OPKO Pharmaceuticals, LLC
$179
Antares Pharma, Inc.
$176
IMPEL PHARMACEUTICALS INC.
$174
Kowa Pharmaceuticals America, Inc.
$172
BioDelivery Sciences International, Inc.
$166
Exact Sciences Corporation
$157
Currax Pharmaceuticals LLC
$151
Neurocrine Biosciences, Inc.
$139
Mannkind Corporation
$136
Bausch Health US, LLC
$122
JAZZ PHARMACEUTICALS INC.
$114
Adlon Therapeutics L.P.
$111
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$111
Collegium Pharmaceutical, Inc.
$106
COMSORT, Inc
$100
VIVUS LLC
$97
Alexion Pharmaceuticals, Inc.
$94
Shire North American Group Inc
$94
Nabriva Therapeutics, plc
$90
Jazz Pharmaceuticals Inc.
$81
Nestle HealthCare Nutrition Inc.
$75
Daiichi Sankyo Inc.
$71
Eisai Inc.
$69
Boston Scientific Corporation
$59
Avion Pharmaceuticals
$58
Celgene Corporation
$56
IDORSIA PHARMACEUTICALS US INC
$52
Zyla Life Sciences, Inc.
$48
Grifols USA, LLC
$47
Intra-Sana Laboratories
$45
Genentech USA, Inc.
$40
SANOFI PASTEUR INC.
$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$33
Seqirus USA Inc
$33
Forte Bio-Pharma LLC
$28
Tactile Systems Technology Inc
$27
Horizon Pharma plc
$25
Inspire Medical Systems, Inc.
$23
GRT US Holding, Inc.
$21
Smith+Nephew, Inc.
$20
Rhythm Pharmaceuticals, Inc.
$19
IBSA Pharma Inc.
$19
Medtronic USA, Inc.
$19
Almatica Pharma LLC
$18
Sanofi Pasteur Inc.
$17
Ironshore Pharmaceuticals Inc.
$16
Circassia Pharmaceuticals Inc
$15
EISAI INC.
$14
LINUS HEALTH, INC.
$14
NESTLE HEALTHCARE NUTRITION INC.
$14
Electronic Waveform Lab, Inc.
$13
Shionogi Inc
$13
MannKind Corporation
$12
Pernix Therapeutics Holdings, Inc.
$11
Purdue Pharma L.P.
$11
Horizon Therapeutics plc
$11
Top 3 companies account for 57.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADACEL · ADHANSIA XR · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · AREXVY · Aimovig · AirDuo Digihaler · Amitiza · ArmonAir Digihaler · Austedo XR · Auvelity · BASAGLAR · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BOOSTRIX · BREO · BREZTRI · BREZTRI AEROSPHERE · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · BYDUREON · BYSTOLIC · CAPLYTA · CATAPRES TTS · CHANTIX · COLLAGENASE SANTYL · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · CORE COGNITIVE EVALUATION · CREON · Cologuard Collection Kit · DUAVEE · DUEXIS · Dayvigo · Dexilant · Dhivy · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre 2 · FreeStyle Libre Pro · GARDASIL · GARDASIL 9 · GEMTESA · GENERAL - PAIN MANAGEMENT · GLYCATE · GLYXAMBI · GRALISE · INGREZZA · INSPIRE · INTELLIS · INVOKANA · Imcivree · JANUVIA · JARDIANCE · Jornay 100 mg capsules (Bottle of 100) · Kerendia · Korlym · LANTUS · LATUDA · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Morphabond ER · Myrbetriq · NALOCET · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · ONZETRA XSAIL · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C Liquid · Prolia · QSYMIA · QULIPTA · QUVIVIQ · Qutenza · RAYALDEE · RELISTOR · RELISTOR ORAL · RELTONE 200 MG · REXULTI · RYBELSUS · Repatha · Rybelsus · S · SEGLENTIS · SHINGRIX · SILENOR · SIVEXTRO · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SPIRIVA RESPIMAT · SPRIX · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYMPROIC · SYNJARDY · SYNTHROID · Saxenda · Seglentis · Sivextro · Strensiq · Symproic · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · Tirosint · Tresiba · Trintellix · Trudhesa · UBRELVY · Uloric · Utibron · VERQUVO · VIBERZI · VIIBRYD · VIMOVO · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XTAMPZAER · XYOSTED · Xenleta · Xofluza · Xtampza ER · ZENPEP · ZEPBOUND · ZORYVE · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
893
Per 100K population
160.9
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gold is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with speaking/promotional industry engagement in the top 1% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gold experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gold performed 388 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gold receive payments from pharmaceutical companies?
Yes. Dr. Gold received a total of $68,955 from 95 companies across 2,033 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gold's costs compare to other family medicine physicians in Lancaster?
Dr. Gold's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gold) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Lancaster
Browse family medicine physicians in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology